Rachel L. Delfanti

Radiology

300 Lombard St
Thousand Oaks, CA 91360

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis.

The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis.

Journal: PloS one

Published: August 23, 2022

Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics.

Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics.

Journal: Journal of neuro-oncology

Published: March 29, 2018

Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.

Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.

Journal: Journal of neuro-oncology

Published: September 15, 2017

Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.

Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.

Journal: Journal of neuro-oncology

Published: March 19, 2017

Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.

Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.

Journal: Neuro-oncology

Published: January 25, 2016

Showing 1-5 of 5

Last Updated: 09/26/2026